ANTIVIRAL DRUG REVIEW A GUIDE TO CLINICIANS

Over the past forty years, there has been a great advance in antiviral infections treatment.The discovery of acyclovir in 1977 paved the way to new antiviral drugs. Other nucleoside analogues such as valacyclovir, penciclovir, famciclovir, anciclovir, valganciclovir, cidofovir and foscarnet were mad...

Descripción completa

Detalles Bibliográficos
Autores: Eline Guerrart Portugal, Magda, Maria Raboni, Sonia
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:Brasil
Institución:Universidade Federal de Goiás (UFG)
Repositorio:Revista de patologia tropical (Online)
Idioma:inglés
OAI Identifier:oai:ojs.revistas.ufg.br:article/46445
Acceso en línea:https://revistas.ufg.br/iptsp/article/view/46445
Access Level:acceso abierto
Palabra clave:antiviral agents
herpes simplex virus
influenza virus
cytomegalovirus
varicella zoster virus
Microbiology
Descripción
Sumario:Over the past forty years, there has been a great advance in antiviral infections treatment.The discovery of acyclovir in 1977 paved the way to new antiviral drugs. Other nucleoside analogues such as valacyclovir, penciclovir, famciclovir, anciclovir, valganciclovir, cidofovir and foscarnet were made available, as well as neuraminidase inhibitors. Also, drugs for the treatment of viral hepatitis and patients with HIV/AIDS have not only increased life quality and expectancy, but also decreased the incidence of some viral infections. Antiviral drugs are important tools to the clinician, especially when treating patients with impaired immunological and clinical condition. Aiming to restore health and prevent further adverse events, the clinician must be aware of the best antiviral drug available, its proper route of administration and dosage. The aim of this review is to present the antiviral drugs currently available, focusing on treatment of common viral infections in clinical practice. A brief description of the mechanisms of action and prescription of antiviral drugs is presented, using the data available from evidence-based medicine.